Previous study demonstrated that the serum ACE2 level can significantly predict the magnitude of coronary artery calcification (CAC), and indicated that elevated ACE2 may be involved in vascular calcification in patients on maintenance hemodialysis therapy [33]. This evidence concerns the gene ACE2 and coronary artery calcification.